Quantitative Correlation at the Molecular Level of Tumor Response to Docetaxel by Multimodal Diffusion-Weighted Magnetic Resonance Imaging and [F]FDG/[F]FLT Positron Emission Tomography
We aimed to quantitatively characterize the treatment effects of docetaxel in the HCT116 xenograft mouse model, applying diffusion-weighted magnetic resonance imaging (MRI) and positron emission tomography (PET) using 2-deoxy-2-[ 18 F]fluoro-D-glucose ([ 18 F]FDG) and 3′-deoxy-3′-[ 18 F]-fluorothymi...
Main Authors: | Valerie S. Honndorf, Holger Schmidt, Hans F. Wehrl, Stefan Wiehr, Walter Ehrlichmann, Leticia Quintanilla-Martinez, Hervé Barjat, Sally-Ann Ricketts, Bernd J. Pichler |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2015-01-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2014.00045 |
Similar Items
-
The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice.
by: Stefan Wiehr, et al.
Published: (2016-01-01) -
Impact of Anesthetics on 3′-[F]Fluoro-3′-Deoxythymidine ([F]FLT) Uptake in Animal Models of Cancer and Inflammation
by: Kerstin Fuchs, et al.
Published: (2013-07-01) -
The use of 18F-Fluoro-deoxy-glucose positron emission tomography (18F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitor.
by: Juliana Maynard, et al.
Published: (2017-01-01) -
Erdheim-Chester Disease: Utility of 18F-FDG Positron Emission Tomography
by: Angelina Cistaro, et al.
Published: (2018-02-01) -
Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals
by: Ioannis Iakovou, et al.
Published: (2018-10-01)